OK
The material selection platform
Plastics & Elastomers
The material selection platform
Plastics & Elastomers
by SpecialChem
 
Save
Cette page a bien été ajoutée à vos favoris

Akulon® Care K1U

Technical Datasheet | Supplied by Envalior
Akulon® Care K1U by Envalior is a low viscosity, non-reinforced, non-flame retarded, polyamide 6 (PA 6). This high-performance grade is processed by injection molding. In-molded parts the material offers an excellent balance of easy design and processing with outstanding mechanical properties over a wide temperature range and in diverse conditions. Akulon® Care K1U is suitable for medical applications. It is used in catheters, IV fluid bags, insulin pens & autoinjectors, surgical robotics and advanced wound care.
REQUEST A SAMPLE ORIGINAL DATASHEET CONTACT SUPPLIER
Akulon® Care K1U
Technical Datasheet | Supplied by Envalior
REQUEST A SAMPLE ORIGINAL DATASHEET CONTACT SUPPLIER
Product Type
PA (Polyamide, Nylon) > PA 6 (Nylon 6)
Product Launch Date
Apr 8, 2022
Product Status
COMMERCIAL
Applications/ Recommended for
  • Healthcare / Medical > Catheters
  • Injection molding - thermoplastics
Key Features
  • Mechanical Properties, Excellent
  • Processability, Good
  • Unfilled
  • Viscosity, Low

Akulon® Care K1U Properties

Mechanical Properties

Value & Unit
Test Condition
Test Method
Nominal Strain at Break
11 %
(At -40°C) 
ISO 527-1/-2
Nominal Strain at Break
20 %
ISO 527-1/-2
Weldline Strain
10 %
(At 4 mm) 
ISO 527-1/-2

Akulon® Care K1U Processing Guidelines

Injection Properties

Value & Unit
Test Condition
Test Method
Melt Residence Time
< 4 min
Nozzle Temperature
240 - 270 °C
Rear Temperature
230 - 235 °C

Want to list or
update your products?
Want to report errors or
suggest improvements?
Access Reliable
Product Information

Database of 99992 Plastics & Elastomers,
reviewed and updated daily

Improve your Product
Selection Experience

Open your choices, compare products,
ask for samples, contact suppliers

Keep-up with latest
Technical Solutions

Be inspired and never miss again crucial
innovations with our weekly email updates

Back to Top